Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221668 | 0.81 | HRH3 (0.34) | HRH3 | |
| SCHEMBL16176158 | 0.79 | MEN1 (0.38) | HRH3 | |
| SCHEMBL23097498 | 0.77 | HRH3 (0.33) | HRH3 | |
| SCHEMBL12134715 | 0.76 | HRH3 (0.35) | HRH3 | |
| SCHEMBL23097458 | 0.76 | HRH3 (0.35) | HRH3 | |
| SCHEMBL7768536 | 0.73 | MEN1 (0.42) | HRH3 | |
| SCHEMBL7768540 | 0.73 | MEN1 (0.42) | HRH3 | |
| SCHEMBL7091906 | 0.72 | HRH3 (0.30) | HRH3 | |
| SCHEMBL14524268 | 0.71 | KDM4E (0.33) | HRH3 | |
| SCHEMBL18347932 | 0.71 | HRH3 (0.32) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060275217-A1 | Chemical exchange saturation transfer contrast agents | EPIX PHARMACEUTICALS, INC. | 2006-12-07 | — | — | US | disclosed |
| WO-2006121889-A2 | CHEMICAL EXCHANGE SATURATION TRANSFER CONTRAST AGENTS | EPIX PHARMACEUTICALS, INC. (US) | 2006-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060275217-A1 | Chemical exchange saturation transfer contrast agents | SLC39A11, SLC30A7, SLC39A7 | HRH3 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.